
Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: Analysis from the phase 3 INVICTUS trial
Số trang: 10
Loại file: pdf
Dung lượng: 2.20 MB
Lượt xem: 13
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Ripretinib is a novel switch-control kinase inhibitor that inhibits KIT and PDGFRA signaling. In the INVIC‑ TUS phase 3 trial, ripretinib increased median progression-free survival and prolonged overall survival vs. placebo in ≥fourth-line advanced GIST. Here, we report prespecified analysis of quality of life (QoL) as assessed by patientreported outcome (PRO) measures and an exploratory analysis evaluating the impact of alopecia on QoL.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Gastrointestinal stromal tumors Patient-reported outcome measures Quality of life Overall survivalTài liệu có liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 178 0 0 -
6 trang 171 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 149 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 134 0 0 -
12 trang 103 0 0
-
19 trang 80 0 0
-
17 trang 70 0 0
-
9 trang 48 0 0
-
11 trang 42 0 0
-
12 trang 41 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 41 0 0 -
9 trang 39 0 0
-
13 trang 39 0 0
-
16 trang 39 0 0
-
11 trang 38 0 0
-
Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
9 trang 38 0 0 -
Tracking tumor alteration in glioma through serum fibroblast activation protein combined with image
10 trang 37 0 0 -
7 trang 37 0 0
-
19 trang 37 0 0
-
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
10 trang 36 0 0